ArticleCancers2023

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Shigeki Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.